Richmond A - Search Results

1

Evaluation of transsphenoidal hypophysectomy in the management of patients with advanced malignant melanoma.

Lawson DH, Nixon DW, Black ML, Tindall GT, Barnes DA, Faraj BA, Ali FM, Camp VM, Richmond A. Lawson DH, et al. Among authors: richmond a. Cancer. 1983 Apr 15;51(8):1541-5. doi: 10.1002/1097-0142(19830415)51:8<1541::aid-cncr2820510831>3.0.co;2-s. Cancer. 1983. PMID: 6186359

2

Preparation of a monoclonal antibody to a melanoma growth-stimulatory activity released into serum-free culture medium by Hs0294 malignant melanoma cells.

Lawson DH, Thomas HG, Roy RG, Gordon DS, Chawla RK, Nixon DW, Richmond A. Lawson DH, et al. Among authors: richmond a. J Cell Biochem. 1987 Jul;34(3):169-85. doi: 10.1002/jcb.240340304. J Cell Biochem. 1987. PMID: 3611199

The majority of this melanoma growth-stimulatory activity (MGSA) resides in a 16-Kd moiety, though bioactivity is also associated with 24-26 and less than 14-Kd forms of MGSA (Richmond and Thomas: J Cell Physiol 129:375, 1986). In order to further characterize this …

The majority of this melanoma growth-stimulatory activity (MGSA) resides in a 16-Kd moiety, though bioactivity is also associated wit …

3

Growth factor and cytogenetic abnormalities in cultured nevi and malignant melanomas.

Richmond A, Fine R, Murray D, Lawson DH, Priest JH. Richmond A, et al. J Invest Dermatol. 1986 Mar;86(3):295-302. doi: 10.1111/1523-1747.ep12285452. J Invest Dermatol. 1986. PMID: 3745955 Free article.

4

Characterization of autostimulatory and transforming growth factors from human melanoma cells.

Richmond A, Lawson DH, Nixon DW, Chawla RK. Richmond A, et al. Cancer Res. 1985 Dec;45(12 Pt 1):6390-4. Cancer Res. 1985. PMID: 3864531

5

Effect of plasma inter-alpha trypsin inhibitor and cancer-related glycoprotein EDC1 on phytohemagglutinin-induced thymidine uptake in lymphocytes.

Chawla RK, Lawson DH, Richmond A, Rudman D. Chawla RK, et al. Among authors: richmond a. Cancer Res. 1980 Nov;40(11):4187-91. Cancer Res. 1980. PMID: 6162547

6

In vitro growth promotion in human malignant melanoma cells by fibroblast growth factor.

Richmond A, Lawson DH, Nixon DW, Stevens JS, Chawla RK. Richmond A, et al. Cancer Res. 1982 Aug;42(8):3175-80. Cancer Res. 1982. PMID: 6212117

7

Elevated plasma and urinary guanosine 3':5'-monophosphate and increased production rate in patients with neoplastic diseases.

Chawla RK, Shlaer SM, Lawson DH, Murray TG, Schmidt F, Shoji M, Nixon DW, Richmond A, Rudman D. Chawla RK, et al. Among authors: richmond a. Cancer Res. 1980 Nov;40(11):3915-20. Cancer Res. 1980. PMID: 6258769

8

Extraction of a melanoma growth-stimulatory activity from culture medium conditioned by the Hs0294 human melanoma cell line.

Richmond A, Lawson DH, Nixon DW, Stevens JS, Chawla RK. Richmond A, et al. Cancer Res. 1983 May;43(5):2106-12. Cancer Res. 1983. PMID: 6600964

9

Metabolic approaches to cancer cachexia.

Lawson DH, Richmond A, Nixon DW, Rudman D. Lawson DH, et al. Among authors: richmond a. Annu Rev Nutr. 1982;2:277-301. doi: 10.1146/annurev.nu.02.070182.001425. Annu Rev Nutr. 1982. PMID: 6821191 Review. No abstract available.

10

Augmenting chemosensitivity of malignant melanoma tumors via proteasome inhibition: implication for bortezomib (VELCADE, PS-341) as a therapeutic agent for malignant melanoma.

Amiri KI, Horton LW, LaFleur BJ, Sosman JA, Richmond A. Amiri KI, et al. Among authors: richmond a. Cancer Res. 2004 Jul 15;64(14):4912-8. doi: 10.1158/0008-5472.CAN-04-0673. Cancer Res. 2004. PMID: 15256463

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

480 results

Search Page